Case Number 4668
Request Date 15/03/2016
Completion Date 21/04/2016 

 

Details of the Request

The total patients treated with the following conditions:

  • Wet age-related macular degeneration (AMD)
  • Diabetic macular oedema (DMO)
  • Macular oedema secondary to retinal vein occlusion, branch (branch RVO)
  • Macular oedema secondary to retinal vein occlusion, central (central RVO)
  • Myopic choroidal neovascularization (mCNV)

 

The volume of use of the following treatment options:

  • Ranibizumab
  • Bevacizamab
  • Aflibercept
  • Dexamethasone intravitreal implant
  • Fluocinolone acetonide intravitreal implant
  • Laser Therapy

 

Details of the Response

1.The total patients treated with the following conditions:

Sent to requester.

 

2.The volume of use of the following treatment options:

Sent to requester.

 

The Trust offers the following laser treatments:

  • YAG laser for post-capsular thickening (cataract patients)
  • SLT laser for glaucoma
  • Peripheral Iridotomy laser for narrow angle glaucoma
  • Macular focal laser or macular grid laser for DMO
  • Pan retinal photocoagulation for proliferative diabetic retinopathy
  • Retinopexy for a retinal tear

 

Please Note:

  • There was no Bevacizumab used during that time period
  • There may be other patients treated for these indications who did not receive one of these drugs so the dataset is possibly not the complete set.